Franco-Aguirre JQ, Cardona-Tapias AA, Cardona-Arias JA. Health-related quality of life of rheumatic disease patients treated in a specialized IPS in Medellin, Colombia. J Med Life. 2017;10(4):223–31.
PubMed PubMed Central CAS Google Scholar
Woolf AD. How to assess musculoskeletal conditions. History and physical examination. Best Pract Res Clin Rheumatol. 2003;17(3):381–402. https://doi.org/10.1016/s1521-6942(03)00027-5.
Uhlig T, Loge JH, Kristiansen IS, et al. Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population. J Rheumatol. 2007;34(6):1241–7.
Slatkowsky-Christensen B, Mownckel P, Loge JH, et al. Health-related quality of life in women with symptomatic hand osteoarthritis: a comparison with rheumatoid arthritis patients, healthy controls, and normative data. Arthritis Rheum. 2007;57(8):1404–9. https://doi.org/10.1002/art.23079.
Sprangers MA, De Regt EB, Andries F, et al. Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol. 2000;53(9):895–907. https://doi.org/10.1016/s0895-4356(00)00204-3.
Article PubMed CAS Google Scholar
Geenen R, Newman S, Bossema ER, et al. Psychological interventions for patients with rheumatic diseases and anxiety or depression. Best Pract Res Clin Rheumatol. 2012;26(3):305–19. https://doi.org/10.1016/j.berh.2012.05.004.
Patterson SL, Park J, Hartogensis W, et al. Perceived stress and prediction of worse patient-reported outcomes in a rheumatoid arthritis cohort. Arthritis Care Res. 2025;77:1085–94.
Haapakosk R, Mathiew J, Ebmeier KP, et al. Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015;49:206–15. https://doi.org/10.1016/j.bbi.2015.06.001.
Kelly KM, Smith JA, Mezuk B. Depression and interleukin-6 signaling: a Mendelian randomization study. Brain Behav Immun. 2021;95:106–14. https://doi.org/10.1016/j.bbi.2021.02.019.
Article PubMed PubMed Central CAS Google Scholar
Ye Z, Kappelmann N, Moser S, et al. Role of inflammation in depression and anxiety: tests for disorder specificity, linearity and potential causality of association in the UK Biobank. EClinicalMedicine. 2021;38:100992. https://doi.org/10.1016/j.eclinm.2021.100992.
Article PubMed PubMed Central Google Scholar
Graham-Engeland J, Demeo NN, Jones DR, et al. Individuals with both higher recent negative affect and physical pain have higher levels of C-reactive protein. Brain Behav Immun Health. 2022;21:100431. https://doi.org/10.1016/j.bbih.2022.100431.
Article PubMed PubMed Central CAS Google Scholar
Geenen R, Finset A. Psycho-social approaches in rheumatic diseases. In: Bijlsma JWJ, da Silva AP, Hachulla E, Doherty M, Cope A, Liote F, editors, EULAR textbook on rheumatic diseases. London; BMJ Group; 2012. p. 139–62.
Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024;331(17):1480–91. https://doi.org/10.1001/jama.2024.2315.
Article PubMed CAS Google Scholar
Ceccarelli F, Ciancarella C, Pirone C, et al. Fibromyalgia, mood disorders and chronic damage are the main determinants of worse quality of life in systemic lupus erythematosus patients: results from a cross-sectional analysis. Lupus. 2024;33(14):1584–93. https://doi.org/10.1177/09612033241299978.
Article PubMed CAS Google Scholar
Zonana-Nacach A, Roseman JM, McGwin G Jr, et al. Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis. LUMINA Study Group. LUpus in MInority populations: NAture vs Nurture. Lupus. 2000;9(2):101–9. https://doi.org/10.1191/096120300678828046.
Palagini L, Tani C, Mauri M, et al. Sleep disorders and systemic lupus erythematosus. Lupus. 2014;23(2):115–23. https://doi.org/10.1177/0961203313518623.
Article PubMed CAS Google Scholar
Cornet A, Karakikla-Mitsakou Z, Andersen J, et al. Experiences and unmet needs of persons living with systemic lupus erythematosus in Europe: lupus Europe’s 2024 Swiss knife survey. Autoimmun Rev. 2025;24(8):103838. https://doi.org/10.1016/j.autrev.2025.103838.
Zhang L, Fu T, Yin R, et al. Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis. BMC Psychiatry. 2017;17(1):70. https://doi.org/10.1186/s12888-017-1234-1.
Article PubMed PubMed Central Google Scholar
Mok CC, Chan KL, Cheung EF, et al. Suicidal ideation in patients with systemic lupus erythematosus: incidence and risk factors. Rheumatology (Oxf). 2014;53(4):714–21. https://doi.org/10.1093/rheumatology/ket404.
Hanly JG, Kozora E, Beyea SD, et al. Review: nervous system disease in systemic lupus erythematosus: current status and future directions. Arthritis Rheumatol. 2019;71(1):33–42. https://doi.org/10.1002/art.40591.
Barbosa F, Mota C, Alves M, et al. Alexithymia in systemic lupus erythematosus patients. Ann N Y Acad Sci. 2009;1173(1):227–34. https://doi.org/10.1111/j.1749-6632.2009.04640.x.
Rapisarda F, Mezzatesta C, Buttice A, et al. Incidence of alexithymia in worsening symptoms and quality of life of systemic lupus erythematosus patients (SLE). J Affect Disord Rep. 2025;20:100874.
Liu X, Jia X, Wang X, et al. Mental health conditions in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Rheumatology (Oxf). 2024;63(12):3234–42. https://doi.org/10.1093/rheumatology/keae239.
Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390(10103):1685–99. https://doi.org/10.1016/S0140-6736(17)30933-9.
Thombs BD, Taillefer SS, Hudson M, et al. Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Rheum. 2007;57(6):1089–97. https://doi.org/10.1002/art.22910.
Schier O, Thombs BD, Hudson M, et al. Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. Arthritis Care Res (Hoboken). 2010;62(3):409–17. https://doi.org/10.1002/acr.20108.
Basta F, Afeltra A, Margiotta DPE. Fatigue in systemic sclerosis: a systematic review. Clin Exp Rheumatol. 2018;36(Suppl 113(4)):150–60.
Del Rosso A, Mikhaylova S, Baccini M, et al. In systemic sclerosis, anxiety and depression assessed by hospital anxiety depression scale are independently associated with disability and psychological factors. Biomed Res Int. 2013;2013(1):507493. https://doi.org/10.1155/2013/507493.
Article PubMed PubMed Central Google Scholar
Wongthawa N, So-Gnern A, Mahakkanukrauh A, et al. Sleep quality and clinical association with sleep disturbance in systemic sclerosis. BMC Rheumatol. 2023;7(1):21. https://doi.org/10.1186/s41927-023-00346-7.
Article PubMed PubMed Central Google Scholar
Chen YT, Lescoat A, Devine A, et al. Cognitive difficulties in people with systemic sclerosis: a qualitative study. Rheumatology (Oxf). 2022;61(9):3754–65. https://doi.org/10.1093/rheumatology/keac004.
Khedr EM, El Fetoh NA, Gamal RM, et al. Evaluation of cognitive function in systemic sclerosis patients: a pilot study. Clin Rheumatol. 2020;39(5):1551–9. https://doi.org/10.1007/s10067-019-04884-9.
Murphy SL, Kratz AL, Whibley D, et al. Fatigue and its association with social participation, functioning, and quality of life in systemic sclerosis. Arthritis Care Res (Hoboken). 2021;73(3):415–22. https://doi.org/10.1002/acr.24122.
Article PubMed PubMed Central Google Scholar
Murphy SL, Whibley D, Kratz AL, et al. Fatigue predicts future reduced social participation, not reduced physical function or quality of life in people with systemic sclerosis. J Scleroderma Relat Disord. 2021;6(2):187–93. https://doi.org/10.1177/2397198320965383.
Poole JL, Chandrasekaran A, Hildebrand K, et al. Participation in life situations by persons with systemic sclerosis. Disabil Rehabil. 2015;37(10):842–5. https://doi.org/10.3109/09638288.2014.944624.
Comments (0)